Fujii F, Onozawa M, Yoshida S, Miyashita N, et al. Real-world treatment patterns and clinical outcomes in patients with AML from 65 to 74 years unfit for first-line intensive chemotherapy in Japan. Int J Hematol 2026;124:167-176.
PMID: 41857430